Autolus Therapeutics PLC (AUTL)
2.80
-0.04
(-1.41%)
USD |
NASDAQ |
Nov 22, 09:33
Autolus Therapeutics Total Assets (Quarterly): 827.49M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 827.49M |
| June 30, 2024 | 853.62M |
| March 31, 2024 | 901.44M |
| December 31, 2023 | 375.38M |
| September 30, 2023 | 406.10M |
| June 30, 2023 | 450.99M |
| March 31, 2023 | 459.97M |
| December 31, 2022 | 490.27M |
| September 30, 2022 | 263.83M |
| June 30, 2022 | 313.98M |
| March 31, 2022 | 363.99M |
| December 31, 2021 | 405.56M |
| Date | Value |
|---|---|
| September 30, 2021 | 296.64M |
| June 30, 2021 | 330.66M |
| March 31, 2021 | 349.75M |
| December 31, 2020 | 294.24M |
| September 30, 2020 | 317.08M |
| June 30, 2020 | 310.55M |
| March 31, 2020 | 337.66M |
| December 31, 2019 | 303.53M |
| September 30, 2019 | 314.64M |
| June 30, 2019 | 346.14M |
| March 31, 2019 | 264.36M |
| March 31, 2018 | 143.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
263.83M
Minimum
Sep 2022
901.44M
Maximum
Mar 2024
432.64M
Average
356.87M
Median
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| NuCana PLC | 25.38M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Bicycle Therapeutics PLC | 996.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 350.52M |
| Shareholders Equity (Quarterly) | 476.96M |